Regulatory

Regulatory basics: why availability differs by country

The same product can be a licensed procedure in one country and an unapproved drug in another. What that does and does not tell you.

5 min read · updated 2026-09-09

Three common frameworks

Jurisdictions typically distinguish minimally manipulated, same-day autologous procedures from products that are processed, expanded or stored — the latter usually regulated as medicines requiring authorisation.

Some countries operate registration or permit pathways for clinics offering regenerative protocols. Registration is a process requirement about facilities and paperwork. It is not a finding that a treatment works.

Reading a regulatory claim

A clinic naming its regulator is a starting point, not a verification. Ask which specific authorisation is held, what it covers, and for the reference number. A permit to operate a facility is a different thing from an authorisation for a specific biologic product.

Travelling for treatment

If you travel, consider who manages complications after you return, what documentation you will be given, whether your local clinicians can act on it, and what recourse exists if something goes wrong in a jurisdiction where you do not live.

Sources and regulatory context

Medical information disclaimer: educational content only. This does not constitute medical advice, diagnosis or treatment. Regulatory status and availability vary by jurisdiction.

Still unsure where to start?

A Navigator can help you organise questions and shortlist providers. We do not diagnose or recommend treatment.

Talk to a Navigator